Toxoplasmosis is one of the most common parasitic diseases worldwide and it poses a serious challenge regarding prevention, diagnosis and therapy. The commonly used diagnostic methods are mostly based on the detection of specific antibodies in sera. Since they are not always accurate enough and do not allow precise definition of the phase of the Toxoplasma gondii infection, there is an urgent need to find specific molecular markers of acute or chronic infection stages. This study provides a comparative assessment of recombinant ROP5 and ROP18 T. gondii proteins in the serodiagnosis of human toxoplasmosis. We found that both ROP5 and ROP18 proteins allowed the detection of specific IgM and IgG antibodies with a relatively low sensitivity; however, ROP18 IgM ELISA proved to be more sensitive than the SAG1 assay. This study also points to a relatively weak potential of the corresponding native ROP5 and ROP18 kinases in the generation of a strong antibody response in humans.
AubertD.,
MaineG. T.,
VillenaI.,
HuntJ. C.,
HowardL.,
SheuM.,
BrojanacS.,
ChovanL. E.,
NowlanS. F.,
PinonJ. M.2000; Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay. J Clin Microbiol 38:1144–1150
ChangP. Y.,
FongM. Y.,
NissapatornV.,
LauY. L.2011; Evaluation of Pichia pastoris-expressed recombinant rhoptry protein 2 of Toxoplasma gondii for its application in diagnosis of toxoplasmosis. Am J Trop Med Hyg 85:485–489 [View Article][PubMed]
CiardelliL.,
MeroniV.,
AvanziniM. A.,
BollaniL.,
TinelliC.,
GarofoliF.,
GasparoniA.,
StronatiM.2008; Early and accurate diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J 27:125–129[PubMed]
DrapałaD.,
Holec-Ga˛siorL.,
KurJ.2015; New recombinant chimeric antigens, P35-MAG1, MIC1-ROP1, and MAG1-ROP1, for the serodiagnosis of human toxoplasmosis. Diagn Microbiol Infect Dis 82:34–39 [View Article][PubMed]
DziadekB.,
GatkowskaJ.,
BrzostekA.,
DziadekJ.,
DzitkoK.,
GrzybowskiM.,
DlugonskaH.2011; Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Vaccine 29:821–830 [View Article][PubMed]
EtheridgeR. D.,
AlagananA.,
TangK.,
LouH. J.,
TurkB. E.,
SibleyL. D.2014; The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice. Cell Host Microbe 15:537–550 [View Article][PubMed]
GatkowskaJ.,
Hiszczyńska-SawickaE.,
KurJ.,
HolecL.,
DlugonskaH.2006; Toxoplasma gondii: an evaluation of diagnostic value of recombinant antigens in a murine model. Exp Parasitol 114:220–227 [View Article][PubMed]
GatkowskaJ.,
DziadekB.,
BrzostekA.,
DziadekJ.,
DzitkoK.,
DługońskaH.2010; Determination of diagnostic value of Toxoplasma gondii recombinant ROP2 and ROP4 antigens in mouse experimental model. Pol J Microbiol 59:137–141[PubMed][CrossRef]
GlorS. B.,
EdelhoferR.,
GrimmF.,
DeplazesP.,
BassoW.2013; Evaluation of a commercial ELISA kit for detection of antibodies against Toxoplasma gondii in serum, plasma and meat juice from experimentally and naturally infected sheep. Parasit Vectors 6:85 [View Article][PubMed]
Holec-Ga˛siorL.2013; Toxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis: current status of studies. Clin Vaccine Immunol 20:1343–1351 [View Article][PubMed]
Holec-Ga˛siorL.,
KurJ.,
Hiszczyńska-SawickaE.2009; GRA2 and ROP1 recombinant antigens as potential markers for detection of Toxoplasma gondii-specific immunoglobulin G in humans with acute toxoplasmosis. Clin Vaccine Immunol 16:510–514 [View Article][PubMed]
JacobsD.,
VercammenM.,
SamanE.1999; Evaluation of recombinant dense granule antigen 7 (GRA7) of Toxoplasma gondii for detection of immunoglobulin G antibodies and analysis of a major antigenic domain. Clin Diagn Lab Immunol 6:24–29[PubMed]
JensenK. D.,
CamejoA.,
MeloM. B.,
CordeiroC.,
JulienL.,
GrotenbregG. M.,
FrickelE. M.,
PloeghH. L.,
YoungL.,
SaeijJ. P.2015; Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination. MBio 6:e02280–e02214 [View Article][PubMed]
MartinV.,
ArcaviM.,
SantillanG.,
AmendoeiraM. R.,
De Souza NevesE.,
GriembergG.,
GuarneraE.,
GarberiJ. C.,
AngelS. O.1998; Detection of human Toxoplasma-specific immunoglobulins A, M, and G with a recombinant Toxoplasma gondii rop2 protein. Clin Diagn Lab Immunol 5:627–631[PubMed]
MeekB.,
van GoolT.,
GilisH.,
PeekR.2001; Dissecting the IgM antibody response during the acute and latent phase of toxoplasmosis. Diagn Microbiol Infect Dis 41:131–137 [View Article][PubMed]
MuratJ. B.,
HidalgoH. F.,
Brenier-PinchartM. P.,
PellouxH.2013; Human toxoplasmosis: which biological diagnostic tests are best suited to which clinical situations?. Expert Rev Anti Infect Ther 11:943–956 [View Article][PubMed]
NiedelmanW.,
GoldD. A.,
RosowskiE. E.,
SprokholtJ. K.,
LimD.,
Farid ArenasA.,
MeloM. B.,
SpoonerE.,
YaffeM. B.,
SaeijJ. P.2012; The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. PLoS Pathog 8:e1002784 [View Article][PubMed]
PfrepperK. I.,
EndersG.,
GohlM.,
KrczalD.,
HlobilH.,
WassenbergD.,
SoutschekE.2005; Seroreactivity to and avidity for recombinant antigens in toxoplasmosis. Clin Diagn Lab Immunol 12:977–982[PubMed]
ReeseM. L.,
ZeinerG. M.,
SaeijJ. P. J.,
BoothroydJ. C.,
BoyleJ. P.2011; Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc Natl Acad Sci U S A 108:9625–9630 [View Article][PubMed]
Roux-BuissonN.,
Fricker-HidalgoH.,
FoussadierA.,
RollandD.,
Suchel-JambonA.-S.,
Brenier-PinchartM.-P.,
PellouxH.2005; Comparative analysis of the VIDAS Toxo IgG IV assay in the detection of antibodies to Toxoplasma gondii
. Diagn Microbiol Infect Dis 53:79–81 [View Article][PubMed]
SaavedraR.,
de MeuterF.,
DecourtJ. L.,
HérionP.1991; Human T cell clone identifies a potentially protective 54-kDa protein antigen of Toxoplasma gondii cloned and expressed in Escherichia coli
. J Immunol 147:1975–1982[PubMed]
SánchezV.,
de-la-TorreA.,
Gómez-MarínJ. E.2014; Characterization of ROP18 alleles in human toxoplasmosis. Parasitol Int 63:463–469 [View Article][PubMed]
SheffieldP.,
GarrardS.,
DerewendaZ.1999; Overcoming expression and purification problems of RhoGDI using a family of parallel expression vectors. Protein Expr Purif 15:34–39 [View Article][PubMed]
Torres-MoralesE.,
TabordaL.,
CardonaN.,
De-la-TorreA.,
Sepulveda-AriasJ. C.,
PatarroyoM. A.,
Gomez-MarinJ. E.2014; Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis. Med Microbiol Immunol (Berl) 203:315–322 [View Article][PubMed]
van GelderP.,
BosmanF.,
de MeuterF.,
van HeuverswynH.,
HérionP.1993; Serodiagnosis of toxoplasmosis by using a recombinant form of the 54-kilodalton rhoptry antigen expressed in Escherichia coli
. J Clin Microbiol 31:9–15[PubMed]